Article info

High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases
Free

Authors

  • Jake A Ruddy Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USADivision of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Caoilfhionn Marie Connolly Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Brian J Boyarsky Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • William A Werbel Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Lisa Christopher-Stine Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Jacqueline Garonzik-Wang Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Dorry L Segev Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USADepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Julie J Paik Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Dorry L Segev, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; dorry{at}jhmi.edu
View Full Text

Citation

Ruddy JA, Connolly CM, Boyarsky BJ, et al
High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases

Publication history

  • Received April 27, 2021
  • Accepted May 9, 2021
  • First published May 24, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.